lidocaine and vinpocetine

lidocaine has been researched along with vinpocetine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J1
Bellman, K; Knegtel, RM; Settimo, L1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Erdö, SL; Lakics, V; Molnár, P1
Achiemere, G; Alpini, D; Hahn, A; Klement, V; Radkova, L; Strouhal, J1
He, J; Huang, Y; Luo, G; Miao, Z; Wang, X; Wang, Y; Wu, T; Zhao, Z1

Other Studies

6 other study(ies) available for lidocaine and vinpocetine

ArticleYear
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
    Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2

    Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase

2008
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Protection against veratridine toxicity in rat cortical cultures: relationship to sodium channel blockade.
    Neuroreport, 1995, Dec-29, Volume: 7, Issue:1

    Topics: Animals; Carbamazepine; Cell Death; Cells, Cultured; Cerebral Cortex; Lidocaine; Neuroprotective Agents; Patch-Clamp Techniques; Phenytoin; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Veratridine; Vinca Alkaloids

1995
Multimodal therapy for chronic tinnitus.
    The international tinnitus journal, 2008, Volume: 14, Issue:1

    Topics: Adult; Aged; Betahistine; Chronic Disease; Cinnarizine; Combined Modality Therapy; Dimenhydrinate; Drug Combinations; Drug Therapy, Combination; Female; Ginkgo biloba; Humans; Lidocaine; Low-Level Light Therapy; Male; Middle Aged; Pentoxifylline; Physical Therapy Modalities; Plant Extracts; Retrospective Studies; Tinnitus; Vinca Alkaloids

2008
The Therapeutic Effect of Stellate Ganglion Block on Facial Nerve Palsy in Patients with Type 2 Diabetes Mellitus.
    European neurology, 2015, Volume: 74, Issue:1-2

    Topics: Adult; Anesthetics, Local; Antipyrine; Aspirin; Autonomic Nerve Block; Blood Glucose; Dexamethasone; Diabetes Mellitus, Type 2; Edaravone; Facial Nerve Diseases; Facial Paralysis; Female; Free Radical Scavengers; Glucocorticoids; Humans; Lidocaine; Male; Middle Aged; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Prednisone; Retrospective Studies; Stellate Ganglion; Thiamine; Treatment Outcome; Vinca Alkaloids; Vitamin B 12; Vitamin B Complex

2015